Frey procedure for chronic pancreatitis: A narrative review

By -

 

Executive Summary

Chronic pancreatitis (CP) is a progressive inflammatory condition characterized by debilitating abdominal pain and the eventual loss of exocrine and endocrine functions. While management follows a "step-up" approach, surgical intervention is required for up to 50% of patients when medical and endoscopic therapies failz. The Frey procedure (FP), which combines local resection of the pancreatic head with longitudinal pancreaticojejunostomy, has emerged as a superior surgical option for patients with an enlarged pancreatic head and no suspicion of malignancy.

Key takeaways include:

  • Superiority in Quality of Life: Compared to pancreaticoduodenectomy (PD), the Frey procedure offers similar long-term pain control but significantly better quality of life (QOL) and lower perioperative morbidity.

  • Technical Advantages: FP is technically less demanding than the Beger procedure as it avoids the division of the pancreatic neck and requires only a single anastomosis, leading to shorter operation times and lower leak rates.

  • Clinical Efficacy: Pain relief is achieved in 48% to 91% of patients. Long-term outcomes regarding diabetes and exocrine insufficiency are primarily driven by the underlying progression of the disease rather than the surgical intervention itself.

  • Early Intervention: Evidence suggests that earlier surgical intervention—before narcotic dependency and multiple failed endoscopic attempts—yields better long-term pain relief.

Overview of Chronic Pancreatitis and Surgical Goals

Chronic pancreatitis is an incurable inflammatory disorder. Its primary symptom, intractable pain, often leads to narcotic addiction, unemployment, and a significant socioeconomic burden. In the United Kingdom alone, the disease costs an estimated £285.3 million annually.

Goals of Surgical Intervention

  1. Pain Alleviation: The foremost priority in management.

  2. Complication Control: Addressing local complications involving adjacent organs (e.g., biliary obstruction).

  3. Function Preservation: Maintaining maximum possible exocrine and endocrine functions.

  4. Rehabilitation: Facilitating social and occupational reintegration.

  5. Quality of Life: Improving the patient’s overall physical and mental well-being.

Rationale: The "Pacemaker" Theory of Pain

The Frey procedure, first described in 1987, is based on the "Pacemaker" theory of pain. This theory identifies an inflammatory mass in the head of the pancreas as the primary driver of disease symptoms. Specifically, the "crucial triangle" between the distal common bile duct, the duct of Wirsung, and the superior mesenteric portal vein is the target for resection.

Unlike the Puestow operation (modified longitudinal pancreaticojejunostomy), which only provides drainage, the Frey procedure addresses the fibrotic, obstructed tissue within the pancreatic head through "coring," while also providing lateral drainage.

Clinical Evaluation and Patient Selection

The decision to proceed with a Frey procedure is typically made by a multidisciplinary team.

Selection Criteria

  • Imaging: Triphasic CT scan (preferred), MRCP, or ERCP to evaluate ductal and parenchymal changes.

  • Anatomy: Pancreatic head enlargement >3.5 cm and a pancreatic duct diameter of ≥5 mm.

  • Malignancy Exclusion: EUS with guided FNA and tumor markers (CA 19.9, CEA) must be utilized if malignancy is suspected. FP is only indicated in the absence of neoplasia.

  • Baseline Assessments: Nutritional status, analgesic intake, and the Izbicki Pain Score (which evaluates pain frequency, intensity via VAS, analgesic potency, and work inability).

Surgical Technique: Key Procedural Steps

The Frey procedure is categorized as an organ-sparing resection.

  • Exposure: Performed via a bilateral subcostal incision. Crucial steps include a Kocher maneuver and the mobilization of the transverse mesocolon to expose the anterior surface of the pancreatic head.

  • Ductal Access: The main pancreatic duct is opened longitudinally from the tail to the head.

  • Coring of the Head: The pancreatic head and uncinate process are cored out using electrocautery. The surgeon leaves a 5 mm rim of pancreatic tissue along the duodenal sweep and the superior mesenteric/portal vein.

  • Biliary Decompression: If biliary obstruction exists, the fibrous tissue restricting the bile duct is excised.

  • Reconstruction: A Roux-en-Y jejunal limb is used for a single-layer pancreaticojejunostomy. A jejunojejunostomy is then performed approximately 60 cm distal to the pancreatic anastomosis.

Analysis of Clinical Outcomes

Short-Term Results

The Frey procedure is associated with low mortality (0%–3%) and manageable morbidity (7%–42%).

Complication

Incidence Rate

Details

Pancreatic Fistula

2% – 15%

Typically Grade A or B; low incidence due to hard pancreatic texture.

Post-Op Hemorrhage

0% – 9%

Source is usually the cored-out cavity; delayed bleeding may involve pseudoaneurysms.

Chest Infection

Common

Most frequent medical complication; mitigated by smoking cessation and physiotherapy.

Hospital Stay

9 – 20 Days

Mean/median duration.

Long-Term Results

  • Pain Control: Success rates range from 48% to 91%. Persistent pain (10%–20% of patients) is often linked to preoperative narcotic use, long duration of pain (>3 years), and continued alcohol consumption.

  • Functional Progression: New-onset Diabetes Mellitus (DM) occurs in 10%–36% of patients, and new-onset Exocrine Pancreatic Insufficiency (EPI) in 7%–83%. Data suggest these are natural consequences of the progressive nature of CP rather than the surgery itself.

  • Weight Gain: Reported in 64%–79% of patients following successful pain relief.

Comparative Performance

The Frey procedure is frequently compared to Pancreaticoduodenectomy (PD/Whipple) and the Beger procedure (duodenum-preserving pancreatic head resection).

Frey vs. Pancreaticoduodenectomy (PD)

  • Perioperative: FP has shorter operation times, less blood loss, and shorter ICU stays.

  • Morbidity: FP has a lower complication rate (19.4% vs. 53.3% in some trials).

  • Survival: Long-term survival is significantly higher in the FP group (mean 14.5 years) compared to the PD group (11.3 years).

  • QOL: Quality of life scores are consistently higher in patients undergoing the Frey procedure.

Frey vs. Beger Procedure

  • Technical Ease: FP does not require dividing the pancreatic neck over the portal vein, reducing the risk of venous injury and bleeding.

  • Anastomosis: FP requires one anastomosis; the Beger requires two, leading to higher leak rates in the latter.

  • Long-Term Equivalence: Both procedures offer comparable long-term pain control, QOL, and preservation of exocrine/endocrine functions.

Conclusion

The Frey procedure stands as a safe, effective, and technically straightforward intervention for chronic pancreatitis characterized by an inflammatory head mass. While it requires surgical experience to optimize the extent of resection and ensure biliary safety, its advantages in perioperative morbidity and long-term quality of life make it a preferred surgical option over more radical resections, provided malignancy has been definitively excluded. Success is most likely when the procedure is performed early in the disease course, prior to the development of chronic pain syndromes and narcotic dependency.